High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects
- 1 April 2001
- journal article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 9 (3) , 248-256
- https://doi.org/10.1053/joca.2000.0382
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Alveolar Macrophages Inhibit Retrovirus-Mediated Gene Transfer to Airway EpitheliaHuman Gene Therapy, 1997
- SOX9 directly regulates the type-ll collagen geneNature Genetics, 1997
- Bcl-2 Lies Downstream of Parathyroid Hormone–related Peptide in a Signaling Pathway That Regulates Chondrocyte Maturation during Skeletal DevelopmentThe Journal of cell biology, 1997
- Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13European Journal of Immunology, 1996
- Gene Therapy: Basic Concepts and Recent AdvancesCritical Reviews™ in Eukaryotic Gene Expression, 1996
- Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation.Journal of Clinical Investigation, 1995
- Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.Journal of Clinical Investigation, 1994
- The immortalized chondrocyte: art without sacrifice.Journal of Clinical Investigation, 1994
- Strategies for Gene Therapy in the LiverSeminars in Liver Disease, 1992
- Effect of transforming growth factor-β1 (TGF-β1) on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiation processExperimental Cell Research, 1992